An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms
International Journal of Molecular Sciences · 05.12.2024 · 25 (23) · 13078
DOI: 10.3390/ijms252313078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.12.2024. Verfasst von Rachel J Moreno und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, University of California, Davis, CA 95616, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIMH NIH HHS, National Institute of Child Health and Disease.
Abstract (Originalsprache)
In the United States, autism spectrum disorder (ASD) affects 1 in 33 children and is characterized by atypical social interactions, communication difficulties, and intense, restricted interests. Microbial dysbiosis in the gastrointestinal (GI) tract is frequently observed in individuals with ASD, potentially contributing to behavioral manifestations and correlating with worsening severity. Moreover, dysbiosis may contribute to the increased prevalence of GI comorbidities in the ASD population and exacerbate immune dysregulation, further worsening dysbiosis. Over the past 25 years, research on the impact of microbial manipulation on ASD outcomes has gained substantial interest. Various approaches to microbial manipulation have been preclinically and clinically tested, including antibiotic treatment, dietary modifications, prebiotics, probiotics, and fecal microbiota transplantation. Each method has shown varying degrees of success in reducing the severity of ASD behaviors and/or GI symptoms and varying long-term efficacy. In this review, we discuss these microbiome manipulation methods and their outcomes. We also discuss potential microbiome manipulation early in life, as this is a critical period for neurodevelopment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, University of California, Davis, CA 95616, USA.
- The M.I.N.D. Institute, University of California, Davis, CA 95817, USA.
ORCID-Profile: Paul Ashwood
Förderung
- NICHD NIH HHS
- NIMH NIH HHS
- National Institute of Child Health and Disease
- National Institutes of Mental Health
- Autism Speaks Foundation
- Autism Research Institute
- Jane Botsford Johnson Foundation
- Grace Gardner Johnson Foundation
Zitieren
APA
Moreno, R. J., & Ashwood, P. (2024). An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms. International Journal of Molecular Sciences, 25(23), 13078. https://doi.org/10.3390/ijms252313078
Vancouver
Moreno RJ, Ashwood P. An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms. International Journal of Molecular Sciences. 2024;25(23):13078. doi:10.3390/ijms252313078
BibTeX
@article{Moreno2024,
author = {Moreno, Rachel J and Ashwood, Paul},
title = {An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13078},
doi = {10.3390/ijms252313078}
}
EUVIMED